Tadawul Saudi Arabia announced the listing and start of trading the shares of Jamjoom Pharmaceutical Factory Company, Jamjoom Pharma, in the main market, as of Tuesday, June 20, 2023.
Tadawul stated in a statement today, Sunday, that the company’s shares will be listed with the Tadawul code 4015 and the international symbol SA15QGU1UNH6, provided that the daily price fluctuation limits are +/- 30%, with the application of fixed limits for price fluctuation at +/- 10%.
And she indicated that these limits will be applied only during the first three days of listing, and starting from the fourth day of trading, the daily price fluctuation limits will be reset to -/+ 10%, and the fixed limits for price fluctuation will be abolished.
The Securities Depository Center Company (Edaa) announced the addition of the subscribed securities in the Jamjoom Pharmaceutical Factory Company, on Thursday, June 15, 2023, to the center’s accounts for eligible shareholders.
The subscription of individual investors in the initial public offering of the Jamjoom Pharmaceutical Factory Company was covered 11 times, with an order value of 1.39 billion riyals.
